Europe's cities offer valuable observation window on new drug trends
Drug problems often emerge, and are most acutely felt, in urban environments, making Europe’s cities a valuable observation window on new drug trends. In its latest report — released recently ahead ofInternational day against drug abuse and illicit trafficking (26 June) —the EU drugs agency (EMCDDA) looks at drugs in cities across Europe, revealing how some cities are developing drug strategies of their own (1).
The European Union is one of the most urbanised areas in the world and its cities are set to become more densely populated. Currently 73 % of the EU’s population resides in cities and this is projected to increase to 82 % (or 30 million new residents) by 2050 (2). The new EMCDDA analysis,Drugs policy and the city in Europe, shows how modern cities play host to a diverse set of drug using populations and related health, social andsecurity problems. The report identifies 10 European capitals with a dedicated drug strategy: Berlin, Bucharest, Copenhagen, Helsinki, Lisbon, Madrid, Prague, Stockholm, Vienna and Warsaw (Figure 2).
EMCDDA Director Wolfgang Götz says: ‘As European cities expand and change, we see the drug problems found in them also evolving. It is within cities that new problems first become visible and we increasingly see innovative policies and measures developing. I believe there is considerable scope for European cities to share their experiences and to learn from each other in this challenging policy area.’
The report, which looks at established and emerging drug problems, focuses on four topics: urban spaces and drug use; businesses and recreational drug use; city-level drug policies; and coordinating and fundingcity-level policies.
Urban spaces and drug use: Eight capital cities report current ‘open drug scenes’ (Figure 1), which can vary from the ‘concentrated’ (up to hundreds of users per day) to the ‘dispersed’ (multiple smaller gatherings), with many fluctuating from one type to the other. Despite these variations, common features exist, namely: the presence of polydrug use (often involving heroin, prescription medications and alcohol); health issues linked to injecting (infection with HIV and hepatitis B and C viruses, discarded injecting materials); and problems relating to congregations of users (criminality, public nuisance). The report explores some of the responses currently used, including: needle- and syringe-exchange programmes; drop-in centres; drug consumption rooms (3); and measures to reduce drug-related litter (e.g. sharp bins, needle-exchange machines).
Businesses and recreational drug use: Cities contain a high density of premises where psychoactive substances are sold and consumed. Frequently, specific areas exist where many of these businesses are clustered together. This can give rise to zones where drug use and intoxication are tolerated, if not accepted. Given the diversity of the drug problems found in such areas, a spectrum of responses is being implemented. These range from prevention and harm-reduction initiatives in recreational settings (e.g. information campaigns, pill-testing) to legislative measures targeting new psychoactive substances and street-based outlets for their sale.
City-level drug policies: The report defines city-level policies as ‘measures taken by local policy actors to address all or some aspects of drug problems in a specific urban location’. It finds that city-level drug strategies frequently mirror the focus of national and regional level documents (Berlin, Helsinki, Lisbon, Madrid, Stockholm, Vienna, Warsaw). Other cities, however, adopt a more thematic approach, addressing specific issues such as: open drug scenes (Copenhagen, Oslo); antisocial behaviour (Dublin) and crack cocaine (London, Paris). Elsewhere (Brussels, Riga, Vilnius), drug issues are included in other city-level strategic documents, such as those focusing on crime or public health. Dedicated local drug monitoring systems exist in some cities, while others use ad hoc methods to monitor drug use.
Coordinating and funding city-level policies: The paper looks at some of the drug coordination arrangements found in European cities. Generally, city authorities are formally responsible for the coordination of city-level drug policy, in some cases, this being established by law (Helsinki, Madrid, Warsaw). Some cities have dedicated drug policy units (Helsinki, Madrid, Paris, Prague, Stockholm, Vienna), while others address drug issues via generic policy units (e.g. London). Officially appointed ‘city drug coordinators’ exist in some capitals (Berlin, Prague, Vienna and Warsaw). Where no formal coordination structures exist at city level, national-, regional- or local-level structures are responsible for strategy implementation (Ankara, Bratislava, Bucharest, Dublin). A number of Europe’s capitals have dedicated drug strategy budgets that fund entire agencies or services provided by agencies. The available expenditure figures range from EUR 6.5 million in Berlin to EUR 29.4 million in Madrid in 2011.
Concluding, Wolfgang Götz said recently: ‘Today, data on drug use at city level are gathered from a variety of sources, with new information emerging from frontline services, hospital emergency departments and wastewater analysis networks. This allows us to gain a more up-to-date view of the state of drug problems at this level and to evaluate the effectiveness of drug policies and responses’(4).
(1) See EMCDDA Papers.
(2) European Commission (2015), Towards an EU research and innovation policy agenda for nature-based solutions and re-naturing cities, Publications Office of the European Union, Luxembourg.
(3) Drug consumption rooms: an overview of provision and evidence
(4) Wastewater analysis and drugs — a European multi-city study
International day against drug abuse and illicit trafficking: The EMCDDA marks this day with an event at its premises for the Lisbon diplomatic community and its partners from the Portuguese authorities. The United Nations Office on Drugs and Crime will be launching its 2015 World Drug Report. Other EMCDDA publications highlighted today: General Report of Activities 2014; A year in review 2014. For more on drugs in Europe, see European Drug Report 2015 package.
Latest News from
Fake & potentially dangerous goods worth nearly €740m stopped at EU customs in 201820/09/2019 12:25:00
New figures released by the EC show that the number of interceptions of fake goods being imported into the EU increased in 2018 due to a large amount of small parcels in express & postal traffic. Almost 27m articles that infringed on intellectual property rights (IPR) were detained in 2018 with a street value of nearly €740m.
ECHA’s scientific committees support restricting PAHs in granules and mulches19/09/2019 12:20:00
The Committee for Socio-economic Analysis (SEAC) has adopted its final opinion supporting the proposal for restricting eight polycyclic aromatic hydrocarbons (PAHs) found in granules and mulches used, for example, in synthetic turf pitches and playgrounds.
July 2019 compared with June 2019 - Production in construction down19/09/2019 11:20:00
Seasonally adjusted production in the construction sector decreased by 0.7% in the euro area (EA19) and by 0.1% in the EU28, according to first estimates from Eurostat, the statistical office of the EU. In June 2019, production in construction increased by 0.6% in the euro area and by 0.1%in the EU28
Collecting litter and data to combat plastic pollution19/09/2019 09:25:00
More and more communities around the world are working against marine litter and plastic pollution. A Danish initiative mobilises schoolchildren to collect plastic waste and research data that will become part of the EEA database on marine litter. Better data on plastic pollution helps inform policies and tackle the problem.
EIOPA establishes Consultative Expert Group on Digital Ethics in Insurance18/09/2019 15:25:00
The European Insurance and Occupational Pensions Authority (EIOPA) yesterday established its Consultative Expert Group on Digital Ethics in Insurance.
EIOPA calls for a sound cyber resilience framework18/09/2019 12:25:00
The European Insurance and Occupational Pensions Authority (EIOPA) has published the report on "Cyber Risk for Insurers – Challenges and Opportunities".
Asylum applications up by 26% in July, but remain dramatically lower than during the 2015-2016 crisis18/09/2019 09:25:00
In July 2019, the monthly number of applications for international protection lodged in the 30 EU+ countries (EU Member States plus Norway & Switzerland) reached approximately 62,900, a 26% increase compared to June. This is slightly higher than in July 2018 (59,375) and roughly the same as in July 2017 (62,040).
Statement by the EC following the working lunch between President Juncker & PM Johnson17/09/2019 15:25:00
President Jean-Claude Juncker and Prime Minister Johnson had a working lunch yesterday in Luxembourg. The aim of the meeting was to take stock of the ongoing technical talks between the EU and the UK and to discuss the next steps.
Control of arms export17/09/2019 14:37:00
The Council has adopted a decision amending the Council Common Position of 8 December 2008 on the control of arms exports, as well as a revised user's guide. It also adopted conclusions on the review of the Common Position.
EC opens in-depth investigations into individual “excess profit” tax rulings granted by Belgium17/09/2019 12:25:00
The EC has opened separate in-depth investigations to assess whether “excess profit” tax rulings granted by Belgium to 39 multinational companies gave those companies an unfair advantage over their competitors, in breach of EU State aid rules.